Exact Mass: 274.009

Exact Mass Matches: 274.009

Found 85 metabolites which its exact mass value is equals to given mass value 274.009, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

D-Glucuronic acid 1-phosphate

1-phospho-alpha-D-galacturonic acid

C6H11O10P (274.009)


KEIO_ID G066

   

6-phospho-2-dehydro-D-gluconate

6-Phospho-2-dehydro-D-gluconate; 2-Dehydro-D-gluconate 6-phosphate

C6H11O10P (274.009)


A ketoaldonic acid phosphate that is the 6-phospho derivative of 2-dehydro-D-gluconic acid.

   

L-Iduronate 2-sulfate

L-Iduronate 2-sulfate

C6H10O10S (273.9995)


   

4-Ketocyclophosphamide

2-[bis(2-chloroethyl)amino]-1,3,2λ⁵-oxazaphosphinane-2,4-dione

C7H13Cl2N2O3P (274.0041)


4-Ketocyclophosphamide is a metabolite of cyclophosphamide. Cyclophosphamide (trade names Endoxan, Cytoxan, Neosar, Procytox, Revimmune), also known as cytophosphane, is a nitrogen mustard alkylating agent, from the oxazophorines group. An alkylating agent adds an alkyl group (CnH2n+1) to DNA. It attaches the alkyl group to the guanine base of DNA, at the number 7 nitrogen atom of the imidazole ring. It is used to treat various types of cancer and some autoimmune disorders. (Wikipedia) D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards

   

3-Dehydro-L-gulonate 6-phosphate

2,4,5-Trihydroxy-3-oxo-6-phosphonooxyhexanoic acid

C6H11O10P (274.009)


3-Dehydro-L-gulonate 6-phosphate is an intermediate in the metabolic pathways of glucose metabolism. Its chemical structure is characterized by a hexose sugar backbone with specific modifications. The "3-Dehydro" part of its name indicates the presence of a double bond at the third carbon atom due to the removal of two hydrogen atoms, which differentiates it from the corresponding sugar. The "L-gulonate" portion refers to its derivation from L-gulonic acid, a sugar acid. The "6-phosphate" indicates the presence of a phosphate group attached to the sixth carbon atom of the sugar. Biologically, 3-Dehydro-L-gulonate 6-phosphate plays a role in the metabolism of glucose. It is involved in the process of gluconeogenesis, which is the synthesis of glucose from non-carbohydrate sources, such as amino acids and glycerol. This pathway is particularly important during periods of fasting or low carbohydrate intake, where the body needs to maintain blood glucose levels for energy production. Additionally, 3-Dehydro-L-gulonate 6-phosphate may also be involved in other metabolic pathways, including the pentose phosphate pathway, which is important for the production of NADPH (an important reducing agent in the cell) and ribose-5-phosphate (a precursor for nucleotide synthesis). In summary, 3-Dehydro-L-gulonate 6-phosphate is a chemically modified sugar phosphate that serves as an intermediate in various metabolic pathways, particularly in the synthesis and breakdown of glucose. Its presence and regulation are crucial for maintaining energy balance and providing necessary building blocks for cellular processes in living organisms.

   

4-Ketoifosfamide

3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2λ⁵-oxazaphosphinane-2,4-dione

C7H13Cl2N2O3P (274.0041)


4-Ketoifosfamide is a metabolite of ifosfamide. Ifosfamide (also marketed as Mitoxana and Ifex) is a nitrogen mustard alkylating agent used in the treatment of cancer. It is sometimes abbreviated IFO. (Wikipedia) D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards

   

D-Glucuronic acid 1-phosphate

(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-(phosphonooxy)oxane-2-carboxylic acid

C6H11O10P (274.009)


D-Glucuronic acid 1-phosphate is an end product of the UDP-glucuronic acid pathway. Formation of free glucuronic acid from UDP-glucuronic acid can be considered as the first step in the synthesis of vitamin C, a pathway that occurs in most vertebrates, although not in guinea pigs and primates, including humans. Free glucuronic acid can also be converted to pentose phosphate intermediates via the pentose pathway. The latter is interrupted in subjects with pentosuria, who have a deficiency in l-xylulose reductase (EC 1.1.1.10, an enzyme that belongs to the short-chain dehydrogenase/reductase family) and excrete abnormal amounts of l-xylulose. Some xenobiotics stimulate the formation of vitamin C in animals and enhance the excretion of l-xylulose in humans with pentosuria and have shown that aminopyrine, metyrapone and other xenobiotics cause an almost instantaneous increase in the conversion of UDP-glucuronic acid to glucuronic acid. It is usually stated that glucuronic acid formation from UDP-glucuronic acid is the result of two successive reactions comprising the hydrolysis of UDP-glucuronic acid to glucuronic acid 1-phosphate and UMP by nucleotide pyrophosphatase (E-NPP3, EC 3.6.1.9), followed by dephosphorylation of glucuronic acid 1-phosphate. Glucuronidation is responsible for conjugating potentially toxic lipophilic compounds with glucuronic acid, thereby producing molecules with greater aqueous solubility that is excreted more readily into urine and bile. The rate at which any compound may be glucuronidated depends on the concentration and activity of the UDP-glucuronosyltransferases as well as the concentration of the cofactor UDP-glucuronic acid. UDP-glucuronic acid is formed after oxidation of UDP-glucose by UDP-glucose dehydrogenase (UGDH, EC 1.1.1.22) with NAD as the electron acceptor. UDP-glucuronic acid may then be either used as the glucuronic acid donor for xenobiotic conjugation reactions by UDPglucuronosyltransferases (GlcAT-P, EC 2.4.1.17), or degraded to D-glucuronic acid 1-phosphate after the phosphodiester bond is cleaved by E-NPP3. E-NPP3 is the same enzyme that further reduces D-Glucuronic acid 1-phosphate to free D-glucuronic acid. Decreases in UDP-glucuronic acid concentration may be due to reduced availability of UDP-glucose or decreased UGDH activity or to increased activities of GlcAT-P or E-NPP3. Exposure to volatile anesthetics reduces hepatic UDP-glucuronic acid concentrations, and alters the rate of conjugation of compounds such as acetaminophen, bilirubin, diethylstilbestrol, iopanoic acid and valproic acid in a non-sex-dependent fashion in experimental mice. The depletion of UDP-glucuronic acid by anesthetics is caused by altered activity of microsomal E-NPP3. (PMID: 2167093, 16689937, 1276) [HMDB] D-Glucuronic acid 1-phosphate is an end product of the UDP-glucuronic acid pathway. Formation of free glucuronic acid from UDP-glucuronic acid can be considered as the first step in the synthesis of vitamin C, a pathway that occurs in most vertebrates, although not in guinea pigs and primates, including humans. Free glucuronic acid can also be converted to pentose phosphate intermediates via the pentose pathway. The latter is interrupted in subjects with pentosuria, who have a deficiency in l-xylulose reductase (EC 1.1.1.10, an enzyme that belongs to the short-chain dehydrogenase/reductase family) and excrete abnormal amounts of l-xylulose. Some xenobiotics stimulate the formation of vitamin C in animals and enhance the excretion of l-xylulose in humans with pentosuria and have shown that aminopyrine, metyrapone and other xenobiotics cause an almost instantaneous increase in the conversion of UDP-glucuronic acid to glucuronic acid. It is usually stated that glucuronic acid formation from UDP-glucuronic acid is the result of two successive reactions comprising the hydrolysis of UDP-glucuronic acid to glucuronic acid 1-phosphate and UMP by nucleotide pyrophosphatase (E-NPP3, EC 3.6.1.9), followed by dephosphorylation of glucuronic acid 1-phosphate. Glucuronidation is responsible for conjugating potentially toxic lipophilic compounds with glucuronic acid, thereby producing molecules with greater aqueous solubility that is excreted more readily into urine and bile. The rate at which any compound may be glucuronidated depends on the concentration and activity of the UDP-glucuronosyltransferases as well as the concentration of the cofactor UDP-glucuronic acid. UDP-glucuronic acid is formed after oxidation of UDP-glucose by UDP-glucose dehydrogenase (UGDH, EC 1.1.1.22) with NAD as the electron acceptor. UDP-glucuronic acid may then be either used as the glucuronic acid donor for xenobiotic conjugation reactions by UDPglucuronosyltransferases (GlcAT-P, EC 2.4.1.17), or degraded to D-glucuronic acid 1-phosphate after the phosphodiester bond is cleaved by E-NPP3. E-NPP3 is the same enzyme that further reduces D-Glucuronic acid 1-phosphate to free D-glucuronic acid. Decreases in UDP-glucuronic acid concentration may be due to reduced availability of UDP-glucose or decreased UGDH activity or to increased activities of GlcAT-P or E-NPP3. Exposure to volatile anesthetics reduces hepatic UDP-glucuronic acid concentrations, and alters the rate of conjugation of compounds such as acetaminophen, bilirubin, diethylstilbestrol, iopanoic acid and valproic acid in a non-sex-dependent fashion in experimental mice. The depletion of UDP-glucuronic acid by anesthetics is caused by altered activity of microsomal E-NPP3. (PMID: 2167093, 16689937, 1276).

   

Ferulic acid 4-sulfate

2-Propenoic acid, 3-[3-methoxy-4-(sulfooxy)phenyl]-, (2E)-

C10H10O7S (274.0147)


Ferulic acid 4-O-sulfate (CAS: 86321-29-1) is a phenolic acid metabolite. It is also a coffee metabolite found in blood or urine. Ferulic acid 4-O-sulfate was found to be elevated in rat urine after whole rye consumption which makes this compound a potential urinary biomarker of whole grain intake (PMID: 26862900). A polyphenol metabolite detected in biological fluids [PhenolExplorer]

   

Isoferulic acid 3-sulfate

(2E)-3-[4-Methoxy-3-(sulphooxy)phenyl]prop-2-enoic acid

C10H10O7S (274.0147)


Isoferulic acid 3-sulfate is a polyphenol metabolite detected in biological fluids (PMID: 20428313).

   

cis-Ferulic acid 4-sulfate

3-[3-Methoxy-4-(sulphooxy)phenyl]prop-2-enoic acid

C10H10O7S (274.0147)


   

Glucuronic acid sulfate

(3,4,5,6-tetrahydroxyoxane-2-carbonyloxy)sulfonic acid

C6H10O10S (273.9995)


   

Iduronate 2-sulfate

2,3,4-Trihydroxy-6-oxo-5-(sulphooxy)hexanoic acid

C6H10O10S (273.9995)


   

(2S,3S,4S,5R)-3,4,5-Trihydroxy-6-sulfooxyoxane-2-carboxylic acid

(2S,3S,4S,5R)-3,4,5-Trihydroxy-6-sulphooxyoxane-2-carboxylic acid

C6H10O10S (273.9995)


   

dimethyl 5-sulphoisophthalate

1,3-dimethyl 5-sulfoisophthalate

C10H10O7S (274.0147)


CONFIDENCE standard compound; INTERNAL_ID 2311

   

6-bromo-1-ethyl-9H-pyrido[3,4-b]indole

6-bromo-1-ethyl-9H-pyrido[3,4-b]indole

C13H11BrN2 (274.0106)


   

RG-14620

α-[(3,5-dichlorophenyl)methylene]-3-pyridineacetonitrile

C14H8Cl2N2 (274.0065)


   

Ferulic acid 4-sulfate

3-[3-methoxy-4-(sulfooxy)phenyl]prop-2-enoic acid

C10H10O7S (274.0147)


A member of the class of cinnamic acids that is ferulic acid in which the phenolic hydrogen has been replaced by a sulfo group.

   

Isoferulic acid 3-sulfate

(2E)-3-[4-methoxy-3-(sulfooxy)phenyl]prop-2-enoic acid

C10H10O7S (274.0147)


   

4-Amino-2-chloro-5-(1H-tetrazol-5-yl)benzenesulfonamide

4-Amino-2-chloro-5-(1H-tetrazol-5-yl)benzenesulfonamide

C7H7ClN6O2S (274.004)


   

N-(2-BROMO-BENZYLIDENE)-N-PHENYL-HYDRAZINE

N-(2-BROMO-BENZYLIDENE)-N-PHENYL-HYDRAZINE

C13H11BrN2 (274.0106)


   

1-(2-BROMOETHYL)PYRROLE

1-(2-BROMOETHYL)PYRROLE

C14H11BrO (273.9993)


   

2,6-Dichloro-4-phenylquinazoline

2,6-Dichloro-4-phenylquinazoline

C14H8Cl2N2 (274.0065)


   

1-((4-BROMOTHIOPHEN-2-YL)METHYL)-4-METHYLPIPERAZINE

1-((4-BROMOTHIOPHEN-2-YL)METHYL)-4-METHYLPIPERAZINE

C10H15BrN2S (274.0139)


   

2-BROMO-5-FLUORO-BENZENEPROPANOIC ACID ETHYL ESTER

2-BROMO-5-FLUORO-BENZENEPROPANOIC ACID ETHYL ESTER

C11H12BrFO2 (274.0005)


   

p-Bromoacetylbiphenyl

p-Bromoacetylbiphenyl

C14H11BrO (273.9993)


   

Magnesium hexafluorosilicate

Magnesium hexafluorosilicate

F6H12MgO6Si (274.0158)


   

Benzyl 4-bromophenyl ketone

1-(4-Bromophenyl)-2-phenylethanone

C14H11BrO (273.9993)


   

T-BUTYL 3-BROMO-4-FLUOROBENZOATE

T-BUTYL 3-BROMO-4-FLUOROBENZOATE

C11H12BrFO2 (274.0005)


   

4-(4-Bromophenyl)acetophenone

4-(4-Bromophenyl)acetophenone

C14H11BrO (273.9993)


   

2-(4-bromophenyl)-1-phenylethanone

2-(4-bromophenyl)-1-phenylethanone

C14H11BrO (273.9993)


   

ethanolate,lanthanum(3+)

ethanolate,lanthanum(3+)

C6H15LaO3 (274.0085)


   

4-BROMO-4-METHYLBENZOPHENONE

4-BROMO-4-METHYLBENZOPHENONE

C14H11BrO (273.9993)


   

tert-Butyl 4-bromo-2-fluorobenzoate

tert-Butyl 4-bromo-2-fluorobenzoate

C11H12BrFO2 (274.0005)


   

5-iodo-1-pentanol acetate

5-iodo-1-pentanol acetate

C7H15IO3 (274.0066)


   

hexaammineruthenium(ii) chloride

hexaammineruthenium(ii) chloride

Cl2H18N6Ru (274.0013)


   

(3-BROMOPHENYL)(P-TOLYL)METHANONE

(3-BROMOPHENYL)(P-TOLYL)METHANONE

C14H11BrO (273.9993)


   

4-CHLORO-2-(4-CHLORO-PHENYL)-QUINAZOLINE

4-CHLORO-2-(4-CHLORO-PHENYL)-QUINAZOLINE

C14H8Cl2N2 (274.0065)


   

4,6-Dichloro-2-phenyl-quinazoline

4,6-Dichloro-2-phenyl-quinazoline

C14H8Cl2N2 (274.0065)


   

2-[Bis(Methylsulfonyl)amino]benzonitrile

2-[Bis(Methylsulfonyl)amino]benzonitrile

C9H10N2O4S2 (274.0082)


   

2,2-dichloro-1-(4-ethoxyphenyl)cyclopropane-1-carboxylic acid

2,2-dichloro-1-(4-ethoxyphenyl)cyclopropane-1-carboxylic acid

C12H12Cl2O3 (274.0163)


   

4-(CHLOROMETHYL)-N-(4-METHYLPHENYL)-1,3-THIAZOL-2-AMINE HYDROCHLORIDE

4-(CHLOROMETHYL)-N-(4-METHYLPHENYL)-1,3-THIAZOL-2-AMINE HYDROCHLORIDE

C11H12Cl2N2S (274.0098)


   

4-BROMO-3-METHYLBENZOPHENONE

4-BROMO-3-METHYLBENZOPHENONE

C14H11BrO (273.9993)


   

6,8-DICHLORO-CHROMAN-3-CARBOXYLIC ACID ETHYL ESTER

6,8-DICHLORO-CHROMAN-3-CARBOXYLIC ACID ETHYL ESTER

C12H12Cl2O3 (274.0163)


   

tert-Butyl 2-bromo-4-fluorobenzoate

tert-Butyl 2-bromo-4-fluorobenzoate

C11H12BrFO2 (274.0005)


   

(7-BROMO-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)(4-BROMOPHENYL)METHANONE

(7-BROMO-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)(4-BROMOPHENYL)METHANONE

C13H11BrN2 (274.0106)


   

4-(Bromomethyl)benzophenone

4-(Bromomethyl)benzophenone

C14H11BrO (273.9993)


   

9,10-Anthracenedione,2-chloro-1,4-dihydroxy-

9,10-Anthracenedione,2-chloro-1,4-dihydroxy-

C14H7ClO4 (274.0033)


   

2-chloro-6-[(E)-2-(4-chlorophenyl)ethenyl]pyridine-3-carbonitrile

2-chloro-6-[(E)-2-(4-chlorophenyl)ethenyl]pyridine-3-carbonitrile

C14H8Cl2N2 (274.0065)


   

2,8-Dinitrodibenzothiophene

2,8-Dinitrodibenzothiophene

C12H6N2O4S (274.0048)


   

2-(2-(4-Chlorophenyl)thiazol-4-yl)ethanamine hydrochloride

2-(2-(4-Chlorophenyl)thiazol-4-yl)ethanamine hydrochloride

C11H12Cl2N2S (274.0098)


   

5-(2-CHLORO-5-(TRIFLUOROMETHYL)PHENYL)FURAN-2-CARBALDEHYDE

5-(2-CHLORO-5-(TRIFLUOROMETHYL)PHENYL)FURAN-2-CARBALDEHYDE

C12H6ClF3O2 (274.0008)


   

4-Bromo-3-fluoro-benzoic acid tert-butyl ester

4-Bromo-3-fluoro-benzoic acid tert-butyl ester

C11H12BrFO2 (274.0005)


   

3-Benzoylbenzyl bromide

3-Benzoylbenzyl bromide

C14H11BrO (273.9993)


   

Ethyl 4-(2,4-dichlorophenyl)-3-oxobutanoate

Ethyl 4-(2,4-dichlorophenyl)-3-oxobutanoate

C12H12Cl2O3 (274.0163)


   

methyl 4-chlorosulfonyl-2,3-dihydro-1H-indene-2-carboxylate

methyl 4-chlorosulfonyl-2,3-dihydro-1H-indene-2-carboxylate

C11H11ClO4S (274.0067)


   

Disulfide, dibenzoyl

Disulfide, dibenzoyl

C14H10O2S2 (274.0122)


   

3-trifluoromethyl-1-phenyl-1H-5-chloropyrazole-4-carbaldehyde

3-trifluoromethyl-1-phenyl-1H-5-chloropyrazole-4-carbaldehyde

C11H6ClF3N2O (274.0121)


   

4-[3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZOYL CHLORIDE

4-[3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZOYL CHLORIDE

C11H6ClF3N2O (274.0121)


   

1-phenyl-5-(trifluoromethyl)pyrazole-4-carbonyl chloride

1-phenyl-5-(trifluoromethyl)pyrazole-4-carbonyl chloride

C11H6ClF3N2O (274.0121)


   
   

5-(2-CHLORO-4-(TRIFLUOROMETHYL)PHENYL)FURAN-2-CARBALDEHYDE

5-(2-CHLORO-4-(TRIFLUOROMETHYL)PHENYL)FURAN-2-CARBALDEHYDE

C12H6ClF3O2 (274.0008)


   

2-(4-chlorophenyl)-5-nitro-1,3-benzoxazole

2-(4-chlorophenyl)-5-nitro-1,3-benzoxazole

C13H7ClN2O3 (274.0145)


   

4 5-diamino-6-hydroxy-2-mercaptopyrimid&

4 5-diamino-6-hydroxy-2-mercaptopyrimid&

C4H10N4O6S2 (274.0042)


   

2-BROMO-2-PHENYLACETOPHENONE

2-BROMO-2-PHENYLACETOPHENONE

C14H11BrO (273.9993)


   

4,7-dichloro-2-phenylquinazoline

4,7-dichloro-2-phenylquinazoline

C14H8Cl2N2 (274.0065)


   

3-(2-Chloroactyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide

3-(2-Chloroactyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide

C7H13Cl2N2O3P (274.0041)


   

(E)-3-(3,5-dichlorophenyl)-2-pyridin-3-ylprop-2-enenitrile

(E)-3-(3,5-dichlorophenyl)-2-pyridin-3-ylprop-2-enenitrile

C14H8Cl2N2 (274.0065)


D000970 - Antineoplastic Agents > D020032 - Tyrphostins

   

3-Sulfoglucuronic acid

3-Sulfoglucuronic acid

C6H10O10S (273.9995)


   

2-O-Sulfo-Alpha-L-Idopyranuronic Acid

2-O-Sulfo-Alpha-L-Idopyranuronic Acid

C6H10O10S (273.9995)


   

2-O-Sulfo-Beta-L-Altropyranuronic Acid

2-O-Sulfo-Beta-L-Altropyranuronic Acid

C6H10O10S (273.9995)


   

2-Keto-6-phosphate-D-gluconic acid, alpha-furanose form

2-Keto-6-phosphate-D-gluconic acid, alpha-furanose form

C6H11O10P (274.009)


   

3-dehydro-L-gulonic acid 6-phosphate

3-dehydro-L-gulonic acid 6-phosphate

C6H11O10P (274.009)


A ketoaldonic acid derivative that is the 6-(dihydrogen phosphate) derivative of 3-dehydro-L-gulonic acid.

   

2-O-sulfo-beta-D-glucuronic acid

2-O-sulfo-beta-D-glucuronic acid

C6H10O10S (273.9995)


   

Hexanediol 1,6-bisphosphate

Hexanediol 1,6-bisphosphate

C6H12O8P2-4 (274.0007)


   

(2S,3S,4S,5R)-3,4,5-Trihydroxy-6-sulfooxyoxane-2-carboxylic acid

(2S,3S,4S,5R)-3,4,5-Trihydroxy-6-sulfooxyoxane-2-carboxylic acid

C6H10O10S (273.9995)


   

cis-Ferulic acid 4-sulfate

cis-Ferulic acid 4-sulfate

C10H10O7S (274.0147)


   

D-Glucuronic acid 1-phosphate

D-Glucuronic acid 1-phosphate

C6H11O10P (274.009)


A uronic acid phosphate consisting of D-glucuronic acid having a phosphate group attached at the 1-position.

   

L-iduronic acid 2-sulfate

L-iduronic acid 2-sulfate

C6H10O10S (273.9995)


   

N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]-3-pyridinecarboxamide

N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]-3-pyridinecarboxamide

C9H5F3N4OS (274.0136)


   

4-Ketocyclophosphamide

4-Ketocyclophosphamide

C7H13Cl2N2O3P (274.0041)


D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards

   

α-D-Glucuronic acid-1-phosphate

1-Phospho-alpha-D-glucuronic acid

C6H11O10P (274.009)


The 1-O-phospho derivative of alpha-D-glucuronic acid.

   

1-phospho-alpha-D-galacturonic acid

1-phospho-alpha-D-galacturonic acid

C6H11O10P (274.009)


An uronic acid phosphate that is alpha-D-galacturonic acid carrying a phosphate group at position 1.

   

4-Ketoifosfamide

4-Ketoifosfamide

C7H13Cl2N2O3P (274.0041)


D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards

   

D-Glucuronate 1-phosphate

D-Glucuronate 1-phosphate

C6H11O10P (274.009)


A carbohydrate acid derivative anion arising from selective deprotonation of the carboxy function of D-glucuronic acid 1-phosphate.